Population Vancomycin Model
Indication: Suspected or confirmed Staphylococcus aureus infections in extremely obese adults
Interactive vancomycin population pharmacokinetic simulator based on Adane et al. 2015 for extremely obese adults, with weight-based volume, creatinine-clearance-based clearance, AUC24 guidance, and trough monitoring context.
Drug Overview
Clinical Context
- Molecular Target
- Vancomycin exposure in extreme obesity
- Drug Class
- Glycopeptide antibiotic
- Therapeutic Area
- Infectious Disease
- Indication
- Suspected or confirmed Staphylococcus aureus infections in extremely obese adults
- Route of Administration
- Intravenous infusion
Model Information
- Model Type
- One-compartment PopPK IV infusion
- Reference
- Adane ED, Herald M, Koura F. Pharmacotherapy. 2015;35:127-139. doi:10.1002/phar.1531
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Population Vancomycin Model allows you to explore concentration-time profiles under different dosing scenarios. The underlying One-compartment PopPK IV infusion model characterizes the pharmacokinetics of this glycopeptide antibiotic following intravenous infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Population Vancomycin Model PK simulator?
This is a free, interactive pharmacokinetic simulator for Population Vancomycin Model used in Suspected or confirmed Staphylococcus aureus infections in extremely obese adults. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Population Vancomycin Model belong to?
Population Vancomycin Model is classified as a Glycopeptide antibiotic that targets Vancomycin exposure in extreme obesity. It is used in the Infectious Disease therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous infusion administration of Population Vancomycin Model. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a One-compartment PopPK IV infusion model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
What is the half-life of Population Vancomycin Model?
Based on the published model parameters, the elimination half-life of Population Vancomycin Model is approximately approximately 8 hours. Note that half-life can vary based on patient-specific factors such as body weight, organ function, and genetic polymorphisms.
Related Simulators
Vancomycin Hemodialysis PopPK Simulator
Serious gram-positive infections requiring IV vancomycin
Voriconazole MIPD Simulator
Invasive fungal infections
Voriconazole
Invasive aspergillosis, candidemia
Oxfendazole Population PK — Tablet Formulation in Healthy African Adults
Onchocerciasis (river blindness)
Shingrix (Recombinant Zoster Vaccine) PK Simulator
Shingles prevention
Prevnar 20 (PCV20) PK Simulator
Pneumococcal disease prevention
Ready to Simulate?
Launch the Population Vancomycin Model simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community